On $1$ October $2021,$ Shildon plc granted $5001$ share appreciation rights $($SARs$)$ to each of its $2,000$ employees. Employees will be eligible to exercise their rights on $30$ September $2024,$ if they remain employed by Shildon plc$.$ On $30$ September $2022,$ Shildon plc estimated that $10\%$ of employees would leave within the vesting

period and forfeit their rights to the SARs. On $30$ September $2023,$ the estimate of total leavers was revised to $25\%.$ On $1$ October $2021,$ the fair value of each $1$ SAR was $5.$ This fair value of each $1$ SAR was $6$ on $30$ September $2022$ and $8$ on $30$ September $2023.$

The SAR liability was correctly calculated in accordance with IFRS $2$ Share$-$based payments on $30$ September $2022.$

Required

Advise the directors of Shildon plc on the accounting treatment of the SARs in the year ended $30$ September $2023.$